Susquehanna International Group
NVO

Susquehanna International Group’s Novo Nordisk NVO Stock Holding History

Susquehanna International Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169M Sell
4,598,900
-3,374,700
-42% -$160M 0.02% 585
2025
Q4 		$406M Buy
7,973,600
+1,153,700
+17% +$59M 0.05% 310
2025
Q3 		$378M Buy
6,819,900
+4,614,500
+209% +$270M 0.04% 337
2025
Q2 		$152M Buy
2,205,400
+872,000
+65% +$59.3M 0.02% 554
2025
Q1 		$92.6M Sell
1,333,400
-561,100
-30% -$46.3M 0.02% 688
2024
Q4 		$163M Buy
1,894,500
+982,400
+108% +$106M 0.02% 499
2024
Q3 		$109M Sell
912,100
-153,100
-14% -$20.4M 0.02% 608
2024
Q2 		$152M Buy
1,065,200
+258,900
+32% +$34.3M 0.03% 434
2024
Q1 		$104M Sell
806,300
-79,600
-9% -$9.48M 0.02% 645
2023
Q4 		$91.6M Sell
885,900
-405,700
-31% -$40.1M 0.02% 716
2023
Q3 		$117M Sell
1,291,600
-144,800
-10% -$12.8M 0.02% 544
2023
Q2 		$116M Buy
1,436,400
+1,006,000
+234% +$82.2M 0.02% 544
2023
Q1 		$34.2M Sell
430,400
-214,400
-33% -$15.2M 0.01% 1219
2022
Q4 		$43.6M Buy
644,800
+190,400
+42% +$11.2M 0.01% 962
2022
Q3 		$22.6M Sell
454,400
-143,800
-24% -$7.7M 0.01% 1326
2022
Q2 		$33.3M Buy
598,200
+217,000
+57% +$12M 0.01% 1080
2022
Q1 		$21.2M Sell
381,200
-574,600
-60% -$29.5M ﹤0.01% 1673
2021
Q4 		$53.5M Buy
955,800
+526,400
+123% +$28.5M 0.01% 1053
2021
Q3 		$20.6M Buy
429,400
+150,400
+54% +$7.27M ﹤0.01% 1937
2021
Q2 		$11.7M Sell
279,000
-600
-0.2% -$23.3K ﹤0.01% 2694
2021
Q1 		$9.43M Sell
279,600
-329,400
-54% -$11.7M ﹤0.01% 2867
2020
Q4 		$21.3M Buy
609,000
+178,600
+41% +$6.17M ﹤0.01% 1677
2020
Q3 		$14.9M Buy
430,400
+281,200
+188% +$9.37M ﹤0.01% 1769
2020
Q2 		$4.88M Buy
149,200
+90,200
+153% +$2.88M ﹤0.01% 3045
2020
Q1 		$1.78M Sell
59,000
-463,600
-89% -$13.8M ﹤0.01% 4179
2019
Q4 		$15.1M Sell
522,600
-22,000
-4% -$609K ﹤0.01% 1677
2019
Q3 		$14.1M Buy
544,600
+26,400
+5% +$668K ﹤0.01% 1636
2019
Q2 		$13.2M Sell
518,200
-212,800
-29% -$5.26M ﹤0.01% 1624
2019
Q1 		$19.1M Buy
731,000
+210,600
+40% +$5.18M 0.01% 1232
2018
Q4 		$12M Sell
520,400
-227,200
-30% -$5.05M ﹤0.01% 1444
2018
Q3 		$17.6M Buy
747,600
+284,400
+61% +$6.94M 0.01% 1421
2018
Q2 		$10.7M Sell
463,200
-144,200
-24% -$3.43M ﹤0.01% 1866
2018
Q1 		$15M Buy
607,400
+283,200
+87% +$7.44M 0.01% 1451
2017
Q4 		$8.7M Sell
324,200
-268,200
-45% -$6.82M ﹤0.01% 1949
2017
Q3 		$14.3M Buy
592,400
+118,400
+25% +$2.68M 0.01% 1488
2017
Q2 		$10.2M Buy
474,000
+240,000
+103% +$4.84M ﹤0.01% 1683
2017
Q1 		$4.01M Buy
234,000
+116,200
+99% +$2.02M ﹤0.01% 2608
2016
Q4 		$2.11M Sell
117,800
-39,800
-25% -$722K ﹤0.01% 3947
2016
Q3 		$3.28M Buy
+157,600
New +$3.91M ﹤0.01% 2774
2016
Q2 		– Sell
-367,200
Closed -$9.95M – 9087
2016
Q1 		$9.95M Buy
367,200
+13,200
+4% +$354K 0.01% 1571
2015
Q4 		$10.3M Buy
354,000
+186,200
+111% +$5.15M ﹤0.01% 1718
2015
Q3 		$4.55M Buy
167,800
+75,800
+82% +$2.15M ﹤0.01% 2806
2015
Q2 		$2.52M Sell
92,000
-14,200
-13% -$399K ﹤0.01% 4207
2015
Q1 		$2.83M Sell
106,200
-49,000
-32% -$1.13M ﹤0.01% 3665
2014
Q4 		$3.28M Sell
155,200
-5,600
-3% -$125K ﹤0.01% 3578
2014
Q3 		$3.83M Buy
160,800
+54,400
+51% +$1.25M ﹤0.01% 3451
2014
Q2 		$2.46M Buy
106,400
+27,800
+35% +$614K ﹤0.01% 4255
2014
Q1 		$1.79M Sell
78,600
-997,400
-93% -$21.3M ﹤0.01% 4514
2013
Q4 		$19.9M Sell
1,076,000
-1,433,000
-57% -$25M 0.01% 1355
2013
Q3 		$42.5M Buy
2,509,000
+275,000
+12% +$4.63M 0.02% 674
2013
Q2 		$34.6M Buy
+2,234,000
New +$37.2M 0.02% 752

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Susquehanna International Group's NVO Position: Q1 2026 in Review

Susquehanna International Group increased its Novo Nordisk (NVO) stake by 809% in Q1 2026, buying an estimated $468M and bringing the position to 11,106,111 shares worth $408M. The position accounts for 0.05% of the portfolio, ranked #315.

Susquehanna International Group first reported a position in NVO in Q2 2013 and has held it in 48 quarters since. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Susquehanna International Group held 11,106,111 shares of Novo Nordisk worth $408M as of Q1 2026.
  • Susquehanna International Group bought 9,884,077 Novo Nordisk shares in Q1 2026, an estimated $468M.
  • Novo Nordisk made up 0.05% of Susquehanna International Group's portfolio in Q1 2026, its #315 holding.
  • Susquehanna International Group first reported a position in Novo Nordisk in Q2 2013 and has held it in 48 quarters since.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.